HSH2D and RAB8A antisense RNA 1 (HSH2D-AS1)

HSH2D and RAB8A antisense RNA 1 (HSH2D-AS1) is a human long non-coding RNA (lncRNA) transcript identified as antisense to the HSH2D and RAB8A genes. While the precise biological functions for this transcript remain unclear, it is categorized as a regulatory lncRNA, as is typical for antisense RNAs, and may influence gene expression mechanisms such as transcription, splicing, or chromatin remodeling. There is limited functional characterization, and it is not established as a protein, drug target, or classical therapeutic target. Its differential expression has been noted in certain cancers and other biological contexts, but no direct therapeutic targeting, associated drugs, actionable biomarkers, or specific safety concerns have been reported[1][5][3]. Notes & explanation: - No evidence from gene/protein databases or gene nomenclature sources establishes "HSH2D-AS1" as a valid or widely studied therapeutic target; it is an antisense RNA linked to the HSH2D and RAB8A loci but not itself a canonical target such as an enzyme or receptor[1][5][3]. - Its functional annotation is primarily as "antisense RNA" or lncRNA; these typically regulate gene expression at different levels (e.g., interfering with transcription, chromatin, or splicing)[3][5]. - There are no known drugs targeting it, and no established role as a clinical biomarker, nor significant safety/therapeutic concerns documented in available sources. - It is considered "incorrect" for therapeutic target mapping because it is neither a receptor, enzyme, transporter, nor other canonical drug target; it is a regulatory RNA with limited characterization. Also, its gene family and function are not those of typical druggable proteins, and information is sparse and possibly derived from an automated gene annotation with little published research.

Not applicable (no known drugs specifically target this RNA)